Progyny, Inc. (PGNY)
Helps employers offer fertility and family-building benefits to their workers.
$30.40-0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+35.2%
The outlook
Progyny is trading near recent highs, sitting 84% of the way up its 52-week range with price above both its 50- and 200-day averages. Analysts overwhelmingly lean Strong Buy, with an average price target about 10% above current levels. The stock carries a trailing P/E of 39.5, reflecting elevated valuation relative to current earnings.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 11 analysts
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +10% vs current price
Analyst price target
~12-month · 11 analysts$33.36average target+9.7% vs now
Now $30.40
Low $27.00High $40.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.38B
52-wk high
$33.07
52-wk low
$16.10
50-day avg
$27.84
200-day avg
$23.13
Trailing P/E
39.5